Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by sah1


PFSCF

RE:Power of Shorts

The BLA is being done by PLI's US subsidiary so you can stop your...

April 5, 2017

PFSCF

RE:RE:BLA

While we all knew this news was coming today, the filing of the Pg BLA is a...

April 5, 2017

PFSCF

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:one of the cool things I heard on the call today was

You may be right, GunnerG. But there has to be some benefit from starting a...

April 2, 2017

PFSCF

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:one of the cool things I heard on the call today was

I got mixed up with my fingers:-). The window for Pg BLA approval is Mid-June...

April 2, 2017

PFSCF

RE:RE:RE:RE:RE:RE:RE:RE:RE:one of the cool things I heard on the call today was

Great info, Gobbs. Given that PLI started the rolling BLA submission in...

April 2, 2017

PFSCF

From ScotiaBank this morning

ProMetic Life Sciences Inc. Q4 First Look – Focused on Pipeline and...

March 31, 2017

PFSCF

From RBC this morning

Impact: Neutral   First impression Q4/16 revenues of $4.1MM vs. our $4...

March 31, 2017

PFSCF

RE:continue research pg,ivig,ipf certain studies 4050

PLI is clued into monetising some of its assets. yesterday's announcement...

March 31, 2017

PFSCF

2016 results

No doubt a loss of  $110.7M is an eye popping - one that is not helped...

March 31, 2017

PFSCF

RE:Correct me if I'm wrong

Yes but our new partners are going to be instrumental in finding pharma...

March 30, 2017

PFSCF

RE:Strategic

Agree H4. I think the model could work equally as well in Japan, which like...

March 30, 2017

PFSCF

RE:That IS a good DEAL !

Yes, fabulous job by Pierre. This model ensures that PLI shareholders will...

March 30, 2017

PFSCF

RE:RE:RE:RE:RE:I hope PL's road map will be questioned at CC

it was Felco who made the wheelchair comment one year ago. Problem is as you...

March 29, 2017

PFSCF

RE:RE:RE:Expiration of Rights

Here is the definition of RSU. Nothing expired. The RSU's were vested...

March 29, 2017

PFSCF

RE:RE:Which is it?

You have hit the nail on the head. Up to management to deliver the regional...

March 28, 2017

PFSCF

RE:RE:RE:FDA priority review voucher bonus

Check out ProMetic BioTherapeutics, Inc and clinicaltrials.gov

March 25, 2017

PFSCF

RE:RE:RE:RE:RE:RE:Cash

You're right. There is the inventory question which will help the cash...

March 24, 2017

PFSCF

RE:RE:RE:RE:Cash

I agree with your numbers Coyote however PLI can never run cash down to zero....

March 24, 2017

PFSCF

RE:Fibrogen3019Phase2open vsPBI-4050EarlyEvidenceEfficacywIPF

Excellent find, Stockbuphoon. It seems 4050 may well be in the lead to become...

March 24, 2017

PFSCF

RE:RE:prometic said they didn't need more money

I agree Closely but the Thomvest loan will provide a longer timeframe to...

March 24, 2017